Thermodynamics Research Center / ThermoML | Journal of Chemical and Engineering Data

Solubility of 7-Chloro-2-methylamino-5-phenyl-3H-1,4-benzodiazepine-4-oxide, 7-Chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one, and 7-Chloro-5-(2-chlorophenyl)-3-hydroxy-1,3-dihydro-1,4-benzodiazepin-2-one in (Propane-1,2-diol + Water) at a Temperature of 303.2 K

Jouyban, A.[Abolghasem], Shokri, J.[Javad], Barzegar-Jalali, M.[Mohammad], Hassanzadeh, D.[Davoud], Acree, Jr., W. E.[William E.], Ghafourian, T.[Taravat], Nokhodchi, A.[Ali]
J. Chem. Eng. Data 2010, 55, 1, 539-542
ABSTRACT
Experimental solubilities of 7-chloro-2-methylamino-5-phenyl-3H-1,4-benzodiazepine-4-oxide (chlordiazepoxide), 7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one (diazepam), and 7-chloro-5-(2-chlorophenyl)-3-hydroxy-1,3-dihydro-1,4-benzodiazepin-2-one (lorazepam) in (propane-1,2-diol + water) at T = 303.2 K were reported. The solubility of drugs increased with the addition of propane-1,2-diol and reached the maximum values in pure propane-1,2-diol. The Jouyban-Acree model was used to fit the experimental data, and the solubilities were reproduced using a previously trained version of the Jouyban-Acree model and the solubility data in monosolvents in which the overall mean relative deviations (OMRDs) of the back-calculated and predicted values with the corresponding experimental data were 4.2 % and 10.7 %. The solubilities of the three drugs were also predicted using a trained version of the log-linear model of Yalkowsky, and the OMRD was 21.1 %.
Compounds
# Formula Name
1 C16H14ClN3O 7-chloro-N-methyl-5-phenyl-3H-1,4-benzodiazepin-2-amine 4-oxide
2 C16H13ClN2O 7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one
3 C15H10Cl2N2O2 lorazepam
4 C3H8O2 1,2-propanediol
5 H2O water
Datasets
The table above is generated from the ThermoML associated json file (link above). POMD and RXND refer to PureOrMixture and Reaction Datasets. The compound numbers are included in properties, variables, and phases, if specificied; the numbers refer to the table of compounds on the left.
Type Compound-# Property Variable Constraint Phase Method #Points
  • POMD
  • 4
  • 1
  • 5
  • Amount concentration (molarity), mol/dm3 - 1 ; Liquid
  • Solvent: Volume fraction - 4; Liquid
  • Temperature, K; Liquid
  • Pressure, kPa; Liquid
  • Liquid
  • Crystal - 1
  • UV/Vis Spectrometry
  • 11
  • POMD
  • 4
  • 1
  • 5
  • Mass density, kg/m3 ; Liquid
  • Solvent: Volume fraction - 4; Liquid
  • Pressure, kPa; Liquid
  • Temperature, K; Liquid
  • Liquid
  • Crystal - 1
  • Pycnometric method
  • 11
  • POMD
  • 4
  • 2
  • 5
  • Amount concentration (molarity), mol/dm3 - 2 ; Liquid
  • Solvent: Volume fraction - 4; Liquid
  • Temperature, K; Liquid
  • Pressure, kPa; Liquid
  • Liquid
  • Crystal - 2
  • UV/Vis Spectrometry
  • 11
  • POMD
  • 4
  • 2
  • 5
  • Mass density, kg/m3 ; Liquid
  • Solvent: Volume fraction - 4; Liquid
  • Pressure, kPa; Liquid
  • Temperature, K; Liquid
  • Liquid
  • Crystal - 2
  • Pycnometric method
  • 11
  • POMD
  • 4
  • 3
  • 5
  • Amount concentration (molarity), mol/dm3 - 3 ; Liquid
  • Solvent: Volume fraction - 4; Liquid
  • Temperature, K; Liquid
  • Pressure, kPa; Liquid
  • Liquid
  • Crystal - 3
  • UV/Vis Spectrometry
  • 11
  • POMD
  • 4
  • 3
  • 5
  • Mass density, kg/m3 ; Liquid
  • Solvent: Volume fraction - 4; Liquid
  • Pressure, kPa; Liquid
  • Temperature, K; Liquid
  • Liquid
  • Crystal - 3
  • Pycnometric method
  • 11